Drug repurposing tactics in the USA: Known active pharmaceutical ingredients in new indications

被引：0
|
作者：
Dooley, Thomas P. [1 ]
机构：
[1] Trends Pharm Dev, 270 Skyline Dr, Trussville, AL 35173 USA
来源：
PULMONARY PHARMACOLOGY & THERAPEUTICS | 2025年 / 89卷
关键词：
Drug repurposing; FDA regulations; Compounding; Medication; Covid-19; SULFOTRANSFERASE;
D O I：
10.1016/j.pupt.2025.102348
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Determination of Thermodynamic Solubility of Active Pharmaceutical Ingredients for Veterinary Species: A New USP General Chapter
    Apley, Mike
    Crist, G. Bryan
    Fellner, Vivek
    Gonzalez, Mario A.
    Hunter, Robert P.
    Martinez, Marilyn N.
    Messenheimer, Janis R.
    Modric, Sanja
    Papich, Mark G.
    Parr, Alan F.
    Riviere, Jim E.
    Marques, Margareth R. C.
    DISSOLUTION TECHNOLOGIES, 2017, 24 (01): : 36 - 39
  • [42] Assay of active pharmaceutical ingredients in drug products based on relative response factors: Instrumentation insights and practical considerations
    Liu, Lisa
    Mouallem, Ariel
    Xiao, Kang Ping
    Meisel, Jerry
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2021, 194
  • [43] Analytical Methodologies to Detect N-Nitrosamine Impurities in Active Pharmaceutical Ingredients, Drug Products and Other Matrices
    Manchuri, Krishna Moorthy
    Shaik, Mahammad Ali
    Gopireddy, Venkata Subba Reddy
    Sultan, Naziya
    Gogineni, Sreenivasarao
    CHEMICAL RESEARCH IN TOXICOLOGY, 2024, 37 (09) : 1456 - 1483
  • [44] Design of arginine-based therapeutic deep eutectic solvents as drug solubilization vehicles for active pharmaceutical ingredients
    Gutierrez, Alberto
    Aparicio, Santiago
    Atilhan, Mert
    PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2019, 21 (20) : 10621 - 10634
  • [45] Control and analysis of hydrazine, hydrazides and hydrazones-Genotoxic impurities in active pharmaceutical ingredients (APIs) and drug products
    Elder, D. P.
    Snodin, D.
    Teasdale, A.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2011, 54 (05) : 900 - 910
  • [46] Assay of active pharmaceutical ingredients in drug products based on relative response factors: Instrumentation insights and practical considerations
    Liu, Lisa
    Mouallem, Ariel
    Xiao, Kang Ping
    Meisel, Jerry
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2021, 194
  • [47] Sample preparation optimization for assay of active pharmaceutical ingredients in a transdermal drug delivery system using experimental designs
    Li, WY
    Nadig, D
    Rasmussen, HT
    Patel, K
    Shah, T
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 37 (03) : 493 - 498
  • [48] Use of a large dataset to develop new models for estimating the sorption of active pharmaceutical ingredients in soils and sediments
    Li, Jun
    Wilkinson, John L.
    Boxall, Alistair B. A.
    JOURNAL OF HAZARDOUS MATERIALS, 2021, 415
  • [49] New multicomponent crystals as a method to improve the physicochemical properties of active pharmaceutical ingredients - three case studies
    Pindelska, E.
    Madura, I.
    Znajdek, K.
    Sarna, A.
    Martin, C.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2022, 78 : E669 - E669
  • [50] A Green Approach for the Determination and Identification of Entacapone Polymorphs in an Active Pharmaceutical Ingredients and Drug Products by FTIR through Absorbance Mode
    Chavan, Rajendra S.
    Ullah, Qasim
    Yadav, Dharmveer Singh
    Pathan, Sabreena Yameen
    Arif, Pathan Mohd
    ANALYTICAL CHEMISTRY LETTERS, 2021, 11 (06) : 828 - 836
12345